Analysis of Clinical Trial Exit Interview Data in Patients with Treatment-Resistant Depression

ConclusionsStandardized interview data provided direct patient insight into the treatment experience from the patient perspective. Data from these interviews assisted in phase III endpoint selection by providing data on relevant concepts in the target treatment-resistant depression population receiving a new treatment, thus enabling the selection of tools to capture noted treatment effects and, by eliminating irrelevant constructs or measures, thereby reducing data “noise.”Trial RegistrationClinicalTrials.gov NCT01640080; NCT01627782.
Source: The Patient - Patient-Centered Outcomes Research - Category: International Medicine & Public Health Source Type: research